Alan E. Fletcher

694 citations

12 papers · 430 indexed · h-index 9

Cellular and Molecular Neuroscience top 10%
- Neuropeptides and Animal Physiology 5
- Neuroscience and Neuropharmacology Research 3
- Neurotransmitter Receptor Influence on Behavior 2
Organic Chemistry
- Synthesis and pharmacology of benzodiazepine derivatives 2
Molecular Biology
- Receptor Mechanisms and Signaling 5
- Pharmacological Receptor Mechanisms and Effects 3
- Cancer therapeutics and mechanisms 2
- Ion channel regulation and function 2
Toxicology
Behavioral Neuroscience

Co-authors: George Marshall Alison J. Smith Smita S. Patel Kerry L. Chapman John Atack Julie Kerby Jonathan D. Silk Charles Adkins
Cited by: Cellular and Molecular Neuroscience Organic Chemistry Molecular Biology
Journals: Journal of Medicinal Chemistry (4 papers)Molecular Pharmacology (3 papers)Bioorganic & Medicinal Chemistry (2 papers)
Partner nations: United States United Kingdom

In The Last Decade

Alan E. Fletcher

12 papers receiving 409 citations

Peers

Countries citing papers authored by Alan E. Fletcher

Since Specialization

Citations

This map shows the geographic impact of Alan E. Fletcher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan E. Fletcher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan E. Fletcher more than expected).

Fields of papers citing papers by Alan E. Fletcher

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alan E. Fletcher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan E. Fletcher. The network helps show where Alan E. Fletcher may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Alan E. Fletcher, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Alan E. Fletcher Line = papers co-authored together Alan E. Fletcher links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

#	Work
1	Effect of α Subunit on Allosteric Modulation of Ion Channel Function in Stably Expressed Human Recombinant γ-Aminobutyric Acid_AReceptors Determined Using³⁶Cl Ion Flux Molecular Pharmacology ·Alison J. Smith,B Lechevallier,Jonathan D. Silk,Charles Adkins,Alan E. Fletcher,AI Olariu,Julie Kerby,George Marshall,Keith A. Wafford,Ruth M. McKernan,John Atack	2001	111
2	Effect of α Subunit on Allosteric Modulation of Ion Channel Function in Stably Expressed Human Recombinant γ-Aminobutyric AcidA Receptors Determined Using 36Cl Ion Flux Molecular Pharmacology ·Alison J. Smith,B Lechevallier,Jonathan D. Silk,Charles Adkins,Alan E. Fletcher,AI Olariu,Julie Kerby,George Marshall,Keith A. Wafford,Ruth M. McKernan,John Atack	2001	1
3	1-(3-Cyanobenzylpiperidin-4-yl)-5-methyl-4-phenyl-1,3-dihydroimidazol-2-one: A Selective High-Affinity Antagonist for the Human Dopamine D₄Receptor with Excellent Selectivity over Ion Channels Journal of Medicinal Chemistry ·Robert W. Carling,Kevin W. Moore,Christopher R. Moyes,Elizabeth A. Jones,鈴木邦和,Frances Emms,R. Marwood,Shil Patel,Smita S. Patel,Alan E. Fletcher,Margaret S. Beer,Bindi Sohal,Andrew Pike,Paul D. Leeson	1999	50
4	Substituted pyrazoles as novel selective ligands for the human dopamine D4 receptor Bioorganic & Medicinal Chemistry ·Michio Kohara,Ian Collins,Joseph G. Neduvelil,Michael Rowley,Paul D. Leeson,Smita S. Patel,Shil Patel,Frances Emms,Rosemarie Marwood,Kerry L. Chapman,Alan E. Fletcher,Graham A. Showell	1998	10
5	3-(1-Piperazinyl)-4,5-dihydro-1H-benzo[g]indazoles: high affinity ligands for the human dopamine D4 receptor with improved selectivity over ion channels Bioorganic & Medicinal Chemistry ·Ian Collins,Michael Rowley,ChigbunduCollins Nwokoro,Frances Emms,Rosemarie Marwood,Shil Patel,Smita S. Patel,Alan E. Fletcher,Ian Ragan,Paul D. Leeson,Ann L. Scott,Theodore P. Broten	1998	20
6	Controlled Modification of Acidity in Cholecystokinin B Receptor Antagonists: N-(1,4-Benzodiazepin-3-yl)-N ‘-[3-(tetrazol-5-ylamino)phenyl]ureas Journal of Medicinal Chemistry ·José L. Castro,Richard G. Ball,Howard B. Broughton,Michael G. N. Russell,Denise Rathbone,Alan P. Watt,Raymond Baker,Kerry L. Chapman,Alan E. Fletcher,Smita S. Patel,Alison J. Smith,George Marshall,P Louge,Victor G. Matassa	1996	59
7	C5-piperazinyl-1,4-benzodiazepines, water-soluble, orally bioa vailable CCKB/gastrin receptor antagonists Bioorganic & Medicinal Chemistry Letters ·Graham A. Showell,Michio Kohara,Stephen R. Fletcher,Joseph G. Neduvelil,Alan E. Fletcher,Stephen B. Freedman,Smita S. Patel,Alison J. Smith,George Marshall,M Berriel-Diaz,Bindi Sohal,Victor G. Matassa	1995	8
8	High-Affinity and Potent, Water-Soluble 5-Amino-1,4-benzodiazepine CCKB/Gastrin Receptor Antagonists Containing a Cationic Solubilizing Group Journal of Medicinal Chemistry ·Graham A. Showell,Michio Kohara,Joseph G. Neduvelil,Stephen R. Fletcher,Raymond Baker,Alan P. Watt,Alan E. Fletcher,Stephen B. Freedman,John A. Kemp	1994	47
9	A Second Generation of Non‐Peptide Cholecystokinin Receptor Antagonists and Their Possible Therapeutic Potential Annals of the New York Academy of Sciences ·Stephen B. Freedman,Smita S. Patel,Alesha Smith,Kerry L. Chapman,Alan E. Fletcher,J A Kemp,Garland R. Marshall,Richard Hargreaves,Pavel Erdakov,里沙石橋,Robert M. DiPardo,Mark G. Bock,Roger Freidinger	1994	8
10	Second-Generation Benzodiazepine CCK-B Antagonists. Development of Subnanomolar Analogs with Selectivity and Water Solubility Journal of Medicinal Chemistry ·Mark G. Bock,Robert M. DiPardo,里沙石橋,C. Shoshi,Daniel F. Veber,高益文,Alison J. Smith,Smita S. Patel,John A. Kemp,George Marshall,Alan E. Fletcher,Kerry L. Chapman,Paul Anderson,Roger Freidinger	1994	33
11	Biological properties of the benzodiazepine amidine derivative L-740,093, a cholecystokinin-B/gastrin receptor antagonist with high affinity in vitro and high potency in vivo. Molecular Pharmacology ·Sima Patel,Alesha Smith,Kerry L. Chapman,Alan E. Fletcher,J A Kemp,Garland R. Marshall,RJ Hargreaves,P Louge,L L Iversen,Susan D. Iversen	1994	35
12	Pharmacological specificity of novel, synthetic, cyclic peptides as antagonists at tachykinin receptors British Journal of Pharmacology ·A.T. McKnight,Janet J. Maguire,D.G. MORRIS,Alan E. Fletcher,Alan C. Foster,Maria Astin-Nielsen,E. Cangiano,J. Longmore,L.L. Iversen	1991	48

About Alan E. Fletcher

Alan E. Fletcher is a scholar working on Cellular and Molecular Neuroscience, Toxicology, Physiology, Psychiatry and Mental health and Molecular Biology, having authored 12 papers that have together received 430 indexed citations. Recurring topics across this work include Receptor Mechanisms and Signaling (5 papers), Neuropeptides and Animal Physiology (5 papers), Neuroscience and Neuropharmacology Research (3 papers), Pharmacological Receptor Mechanisms and Effects (3 papers), Cancer therapeutics and mechanisms (2 papers), Synthesis and pharmacology of benzodiazepine derivatives (2 papers), Ion channel regulation and function (2 papers) and Neurotransmitter Receptor Influence on Behavior (2 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (229 citations), Organic Chemistry (130 citations), Molecular Biology (223 citations), Toxicology (11 citations) and Behavioral Neuroscience (10 citations). Alan E. Fletcher has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include George Marshall, Alison J. Smith, Smita S. Patel, Kerry L. Chapman, John Atack, Julie Kerby, Jonathan D. Silk, Charles Adkins, Keith A. Wafford and Ruth M. McKernan. Their work appears in journals such as Journal of Medicinal Chemistry, Molecular Pharmacology, Bioorganic & Medicinal Chemistry, Bioorganic & Medicinal Chemistry Letters and British Journal of Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact